The Role of MAP Kinase in The Signal Transduction Pathways Activated by Mechanical Stress in Mesenchymal Cells.
The Role of MAP Kinase in The Signal Transduction Pathways Activated by Mechanical Stress in Mesenchymal Cells.
批准号:
09672094
负责人:
MORIYAMA Keiji
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
白细胞介素-6(IL-6)在机械应力下骨代谢中的作用研究日益增多。然而,其对成骨细胞的影响仍然不清楚,因为结果是相互矛盾的,这取决于所采用的研究模型。我们推断这些相互矛盾的数据是由于膜结合IL-6受体(IL-6 Rs)的表达水平不同。在本研究中,我们发现,IL-6与可溶性IL-6 R(sIL-6 R)的组合始终引起碱性磷酸酶的显着升高和人成骨细胞系MG-63,其中表达没有检测到的膜结合IL-6 R,未能响应IL-6的增殖减少。IL-6/sIL-6 R的这些作用可被IL-6信号转导蛋白gp 130的中和抗体阻断,提示IL-6信号转导参与了IL-6/sIL-6 R的作用。此外,信号转导子和转录激活子STAT 1和STAT 3也被酪氨酸磷酸化,易位到细胞核,并结合到推定的STAT结合DNA元件。此外,IL-6/sIL-6 R还激活了丝裂原活化蛋白(MAP)激酶,这些数据表明sIL-SR可以增强MG-63细胞对IL-6的反应性。因此,IL-6与sIL-6 R协同作用可能通过激活JAK-STAT和MAP激酶两条不同的信号通路来调节成骨细胞的分化和增殖。
英文摘要
Studies on interleukin-6 (IL-6) in bone metabolism in response to mechanical stress have been accumulating. However, its effects on osteoblasts are still unclear because the results are conflicting depending on the study models employed. We reasoned that these conflicting data are due to variable expression levels of membrane-bound IL-6 receptors (IL-6Rs). In the present study, we found that IL-6 in combination with soluble IL-6R (sIL-6R) consistently caused a marked elevation of alkaline phosphatase and a decrease in proliferation in the human osteoblastic cell line MG-63, which expressed no detectable membrane-bound IL-6R and failed to respond to IL-6. These effects of IL-6/sIL-6R were blocked by neutralizing antibodies to the IL-6 signal transducer gp 130, suggesting an involvement of IL-6 signaling in the elicitation of the effects of IL-6/sIL6R.Upon stimulation with IL-6/sIL-6R, the gp 130, cytoplasmic Janus kinases JAK1 and JAK2 were tyrosine phosphorylated. Moreover, signal transducers and activators of transcription STAT1 and STAT3 were also tyrosine phosphorylated, translocated to the nucleus, and bound to the putative STAT-binding DNA elements. In addition, mitogen-activated protein (MAP) kinase was also activated in response to IL-6/sIL-6R.These data demonstrate that sIL-SR may enhance the responsiveness of MG-63 cells to IL-6. Thus, IL-6 in collaboration with sIL-6R may modulate differentiation and proliferation of osteoblastic cells, presumably by activating two distinct signaling pathways of JAK-STAT and MAP kinase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
R.Nishimura et al.: "Combination of Interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-Stat and MAP kinase pathways in MG-63 human osteoblastic osteosarcoma cells." J.Bone and Mineral Res.13・5. 777-785 (1998)
R. Nishimura 等人:“白细胞介素 6 和可溶性白细胞介素 6 受体的组合可诱导 MG-63 人成骨细胞骨肉瘤细胞中 JAK-Stat 和 MAP 激酶途径的分化和激活,J.Bone and Mineral Res.13・” 5.777-785(1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Moriyama et al.: "Transactions,8th International Congress on Cleft Palate and Related Craniofacial Anomalies" S.T.Lee,Stamford Press Pte Ltd,Singapore, 1066 (1997)
K.Moriyama 等人:“交易,第八届腭裂和相关颅面异常国际大会”S.T.Lee,Stamford Press Pte Ltd,新加坡,1066 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.funato et al.: "Evidence for apoptosis sigulating kinase(ASK)1 in the regenerating palatal epithelium upon acute injury." Lab.Invest.78・4. 477-483 (1998)
N.funato 等人:“急性损伤后腭上皮细胞凋亡调节激酶 (ASK)1 的证据。Lab.Invest.78·4 (1998)”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Yokozeki et al.: "Interferon-γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-β1 in vitro." FEBS Letters. 442・1. 61-64 (1999)
M. Yokozeki 等人:“干扰素-γ 抑制体外转化生长因子-β1 诱导的大鼠腭成纤维细胞表型。” FEBS Letters 61-64 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.MOriyama et al.: "Transactions,8th international Congress on Cleft Palate and Related Craniofacial Anomalies" S.T.Lee, Stamford Press Pte Ltd,Singapore, 1066 (1997)
K.MOriyama 等人:“第 8 届国际腭裂及相关颅面异常大会交易”S.T.Lee,Stamford Press Pte Ltd,新加坡,1066 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Elucidation of etiology of facial asymmetry based on integrated genome-phenome analysis
-
批准号:19H03857
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2019
-
负责人:MORIYAMA Keiji
-
依托单位:
International comparative study on craniofacial morphology of Mongolian adolescents
-
批准号:25305037
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2013
-
负责人:MORIYAMA Keiji
-
依托单位:
Development of new technology for controlling suture remodeling using magnetized liposome with liposome
-
批准号:23659963
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:MORIYAMA Keiji
-
依托单位:
Development of new therapeutic strategy for the craniosynostosis patients
-
批准号:23390471
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2011
-
负责人:MORIYAMA Keiji
-
依托单位:
Basic study for developing new therapies and its practical use for craniofacial anomalies
-
批准号:18209060
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.37万
-
财政年份:2006
-
负责人:MORIYAMA Keiji
-
依托单位:
Mechanism of bone destruction due to Rheumatoid Arthritis in the fields of Osteoimmunology
-
批准号:15390637
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.22万
-
财政年份:2003
-
负责人:MORIYAMA Keiji
-
依托单位:
The function of periostin during periodontal tissue remodeling caused by mechanical stress.
-
批准号:13470452
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.37万
-
财政年份:2001
-
负责人:MORIYAMA Keiji
-
依托单位:
Establishment of new treatment for cleft lip and palate patients-basic research for the application of in vitro hybrid artificial bone-
-
批准号:12557185
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.93万
-
财政年份:2000
-
负责人:MORIYAMA Keiji
-
依托单位:
REGULATION OF OSTEOCLASTIC BONE RESORPTION BY RHO
-
批准号:11694283
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$2.05万
-
财政年份:1999
-
负责人:MORIYAMA Keiji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
-
批准号:JCZRLH202601296
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
-
批准号:JCZRLH202600985
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
-
批准号:JCZRLH202601410
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于"热证可灸"理论的中药联合铺棉灸治疗带状疱疹急性期的临床疗效及对血清SP、β-EP、IL-6、IL-10、NSE水平的影响
-
批准号:2026JJ81075
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄迎春
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于IL-6/STAT3通路巨噬细胞极化调控免疫反应在胸膜结核瘤形成中的机制
-
批准号:2026JJ82516
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张锋
-
依托单位:
基于“截断扭转”学说探讨凉膈散通过IL-6/STAT3/RORγt轴调控脓毒症Th17/Treg稳态的机制及临床研究
-
批准号:2026JJ82600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄磊
-
依托单位:
从肝失疏泄探讨肝脏代谢物介导IL-6/STAT3通路调控GABA能系统对睡眠节律影响的机制及逍遥散的干预作用
-
批准号:2026JJ30175
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:滕永杰
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: